Computer And Related Services Tenders

Open House Discount Contracts 2023-02

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Edoxaban, Atc B01af03 for the Period April 1St, 2023 - March 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Eslicarbazepine Acetate, Atc N03af04 for the Period April 1St, 2023 - March 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Colecalciferol (Atc Code: A11cc05).

Open House Contracts for Multiple Active Ingredients/Active Ingredient Combinations

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Dornase Alfa (Atc Code: R05cb13).

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Sevelamer Hydrochloride (Atc Code: V03ae02).

Drug Rebate Contracts with Option to Join - 0004-Rvbeitr.59-2023

Open House Procedure Contract According to § 31 Paragraph 1 and 1A Sgb V on the Supply of Bandages

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Calcium Carbonate and Colecalciferol (A12ax01) as Part of an Open House Model.